Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Its time for the beleaguered drug stocks to take their turn in the stock market run-up. They have been left behind for the most part, and the PEs seem to reflect that none will be left in business in a few years. We know that is not the truth and it makes sense that Bristol-Myers has a great chance to grow as they have bought seven companies since October 2007 and have positioned themselves to become a leader in the Cancer treatment industry.